U.S. Biotech Stock News

If you are wondering whether Cardinal Health's share price still reflects fair value after its strong run, you are not alone. This article will walk through what the current numbers might be telling you. The stock last closed at US$229.23, with returns of 2.1% over 7 days, 9.0% over 30 days, 11.4% year to date, 79.3% over 1 year and 221.6% over 3 years. This naturally raises questions about how much of the story is already priced in. Recent news flow around Cardinal Health has focused on its...

Why Triumph Financial is on investors’ radar today Triumph Financial (TFIN) has drawn fresh attention after a period where the stock logged a 10.4% decline over the past week and a 11.8% drop over the past month. Those short term moves come against a mixed backdrop of returns over longer horizons. This creates a natural pause point for investors assessing how the bank’s current US$55.86 share price lines up with its recent financial results. See our latest analysis for Triumph...

Supernus Pharmaceuticals reported record revenues in 2025. The company completed the integration of Sage Therapeutics. New products ONAPGO for Parkinson's disease and ZURZUVAE for postpartum depression were launched. The business expanded into new therapeutic areas despite supply constraints. For investors looking at NasdaqGM:SUPN, these company updates come with a stock that last closed at $54.73 and has returned 70.7% over the past year. Over 3 years the stock is up 37.5%, and over 5...

If you are wondering whether Trustmark's current share price lines up with its underlying value, this article is designed to walk you through that question in a clear, practical way. Trustmark's share price recently closed at US$42.59, with returns of a 4.8% decline over 7 days, 1.1% over 30 days, 9.0% year to date, 19.3% over 1 year, 59.7% over 3 years and 48.4% over 5 years. These price moves are sitting against a backdrop of ongoing interest in US regional banks. In this space, investors...

FMC Corporation recently announced that the Herbicide Resistance Action Committee classified its herbicide rimisoxafen as the first-ever dual mode of action product under HRAC Groups 12 and 32, while also declaring a regular quarterly dividend of US$0.08 per share payable on April 16, 2026, to shareholders of record on March 31, 2026. HRAC’s unprecedented dual classification underscores rimisoxafen’s potential role as an important tool against herbicide-resistant weeds such as palmer...

Magnolia Oil & Gas (MGY) has been in focus after its fourth quarter 2025 earnings slightly missed forecasts, yet the stock recently touched a 52 week high and management appeared at the THRIVE Energy Conference. See our latest analysis for Magnolia Oil & Gas. The recent move to a US$27.82 share price, alongside Magnolia Oil & Gas touching a 52 week high, comes after a 10.31% 30 day share price return and a 23.75% year to date share price return. The 5 year total shareholder return of 139.20%...

What recent performance tells you about Bio-Techne Bio-Techne (TECH) has seen mixed share performance recently, with gains of 1.9% over the past day and 2.6% over the past week, set against declines over the month and past 3 months. See our latest analysis for Bio-Techne. At a share price of US$59.0, Bio-Techne’s recent 1-day and 7-day share price gains come after a 1-year total shareholder return decline of 3.9% and a 5-year total shareholder return decline of 32.3%. This suggests short-term...

Aon plc announced that Nick Fraccalvieri was appointed CEO of global facultative for Aon’s Reinsurance Solutions, effective March 1, 2026, while retaining his EMEA facultative leadership role and succeeding Andrew Laing, who remains global chair of facultative and UK CEO. This leadership shift places ceded facultative, digital capabilities, and talent development at the center of Aon’s global facultative reinsurance ambitions in an increasingly complex risk landscape. We’ll now examine how...

Why Principal Financial Group’s shelf registration and rating change matter now Principal Financial Group (PFG) has filed an omnibus shelf registration covering common and preferred stock, debt, depositary shares, warrants, purchase contracts, and purchase units, giving the company flexibility to raise capital when needed. At the same time, a Wells Fargo analyst moved the stock to an Equal-Weight rating after mixed earnings and valuation concerns. This combination puts financing options and...

Sunrun (RUN) closed out FY 2025 with Q4 revenue of US$1.2 billion and basic EPS of US$0.45, while trailing twelve month EPS sat at US$1.96 on revenue of US$3.0 billion. The company has seen quarterly revenue range from US$504.3 million to US$1.2 billion through 2025, with basic EPS moving from US$0.22 in Q1 to US$1.22 in Q2 and US$0.07 in Q3 before landing at US$0.45 in Q4, alongside a trailing twelve month net income of US$449.9 million. For investors, the key question now is how durable...

Terns Pharmaceuticals recently drew fresh attention after Leerink Partners initiated coverage with an Outperform rating, while hedge fund ownership in the stock climbed during the fourth quarter of 2025. The focus on TERN-701, a next-generation allosteric inhibitor for chronic myeloid leukemia, underscores how a single pipeline asset can reshape institutional interest in a clinical-stage biotech. We will now examine how this growing hedge fund interest around TERN-701 influences Terns...

If you are wondering whether Dycom Industries' share price still lines up with its underlying worth, this article will walk through what the current market price might be implying about the business. The stock recently closed at US$418.24, with returns of 13.0% over the last 30 days, 20.3% year to date, 155.2% over 1 year, 313.6% over 3 years and 377.8% over 5 years. This raises fair questions about how much optimism is already priced in. Recent news coverage has focused on Dycom Industries'...

Chewy (NYSE:CHWY) has entered a collaboration with WeShop that rewards customers with equity tied to their purchases. The company has appointed Christopher S. Deppe as its new CFO, drawing on his background at Amazon and his prior roles within Chewy. Chewy, trading at $27.395, is rolling out an equity incentive model through WeShop that turns regular shopping activity into a potential ownership stake for customers. This comes as the stock shows mixed recent performance, with a 3.6% gain...

American Express, NYSE:AXP, has announced plans to become the sole tenant of a new global headquarters at 2 World Trade Center in New York City. The company plans a state of the art tower focused on future ready technology, employee well being, and sustainability. The development is expected to play a meaningful role in the local economy and stand out as a major corporate real estate move within the financial sector. For investors watching NYSE:AXP, the new headquarters plan comes at a time...

Borr Drilling secured several contract extensions and new assignments for its jack-up rigs across Mexico, Brunei, the U.S., Gabon, Congo and Germany. The updates cover both existing contracts being extended and rigs moving to fresh work with different clients and regions. The new activity reflects continued use of Borr Drilling's jack-up fleet across a wider geographic footprint. Borr Drilling (NYSE:BORR) is drawing attention after these fresh contract wins, with the stock recently trading...

In recent days, American Eagle Outfitters has faced macro headwinds from new global import tariffs and inflation worries, while also announcing warehouse closures and winding down its Quiet Logistics third‑party services, resulting in 211 planned layoffs across two U.S. distribution centers. At the same time, analysts have become more optimistic about American Eagle’s earnings outlook and brand traction, supported by positive revenue trends and fresh marketing efforts like its expanded Jeans...

General Mills, NYSE:GIS, has reduced its full year sales and profit outlook as consumers shift toward lower priced private label products. The company is accelerating development of protein based offerings, aiming for a larger share of future revenue from this category. Senior leader Donald Monk is leaving General Mills to become Chief Technology Officer at Hormel Foods, marking a significant management change. General Mills shares recently closed at $45.23, with the stock down 21.7% over...

Amneal Pharmaceuticals (AMRX) has just posted its FY 2025 numbers, with Q4 revenue of US$814.3 million and basic EPS of US$0.11, capping a trailing twelve month run of US$3.0 billion in revenue and EPS of US$0.23. Over recent quarters the company has seen revenue move from US$702.5 million in Q3 2024 to US$730.5 million in Q4 2024, then to US$695.4 million, US$724.5 million, US$784.5 million and finally US$814.3 million through FY 2025, while quarterly EPS shifted from a loss of US$0.10 to...

Mondelez International (NasdaqGS:MDLZ) has appointed Ziad Abla as Managing Director for Mondelez Arabia. The new leadership role covers Saudi Arabia, one of the company’s key markets in the Middle East. Abla is set to oversee growth, commercial execution, and broader transformation initiatives in the region. For investors following NasdaqGS:MDLZ, this move sits within Mondelez International’s broader focus on snacks and confectionery across global markets, including the Gulf. Saudi Arabia...

The St. Joe Company reported past fourth-quarter 2025 results showing sales of US$60.7 million and revenue of US$128.9 million, with full-year 2025 revenue of US$513.25 million and net income of US$115.63 million, alongside a US$0.16 per-share dividend declaration and continued share repurchases. Recent expansions of its Watersound Real Estate platform and other asset-light businesses highlight St. Joe’s focus on growing recurring, service-based revenue linked to its Florida...

Abercrombie & Fitch (NYSE:ANF) is opening a new store at Pinecrest, expanding its physical retail presence. The brand’s Convertible Mesh Multiway Top is going viral on TikTok, driven by strong consumer interest. Abercrombie & Fitch, trading at around $97.65, comes into this news with mixed recent performance. The share price is down 21.1% year to date and 5.2% over the past year, while the 3 year and 5 year returns are both above 200%. For investors, that blend of recent pullback and longer...

Archrock (AROC) has drawn fresh attention after a recent move in its share price, with the stock now trading around $35.24. This has prompted investors to reassess its valuation and income profile. See our latest analysis for Archrock. The recent pullback in Archrock’s share price follows a strong run, including a 24.22% 30-day share price return and a 32.33% year-to-date share price return, along with a very large 5-year total shareholder return that reflects reinvested dividends and other...

DigitalBridge Group (NYSE:DBRG) released its latest quarterly financial results and paused regular quarterly guidance. The company decided not to host its usual earnings call, citing a proposed transaction with SoftBank Group Corp. The SoftBank proposal could lead to meaningful changes in DigitalBridge Group's business structure or ownership. DigitalBridge Group, a digital infrastructure investment firm, operates at the intersection of data centers, connectivity and related assets that...

Wondering if Ouster at around US$18.95 is still offering value after a volatile few years, or if most of the easy upside is already reflected in the price. The stock has been on a wild ride, with a 1.8% gain over the last 7 days, a 20.6% decline over 30 days, an 18.9% decline year to date, a 129.7% return over 1 year and a 69.2% return over 3 years, compared with an 84.2% decline over 5 years. Recent news coverage around Ouster has largely focused on its role in the lidar and sensor space...